{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:08Z","timestamp":1791118748569,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.ahj.2004.12.005","type":"journal-article","created":{"date-parts":[[2005,9,17]],"date-time":"2005-09-17T07:12:00Z","timestamp":1126941120000},"page":"426-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Effects of eplerenone versus losartan in patients with low-renin hypertension"],"prefix":"10.1016","volume":"150","author":[{"given":"Myron H.","family":"Weinberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis-Miguel","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Roniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.12.005_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0733-8651(02)00003-6","article-title":"Pathogenesis and clinical physiology of hypertension","volume":"20","author":"Bakris","year":"2002","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ahj.2004.12.005_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.30.2.163","article-title":"Nocturnal decline in blood pressure is attenuated by NaCl loading in salt-sensitive patients with essential hypertension: noninvasive 24-hour ambulatory blood pressure monitoring","volume":"30","author":"Higashi","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.12.005_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.jhh.1001127","article-title":"Why is plasma renin activity lower in populations of African origin?","volume":"15","author":"Sagnella","year":"2001","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ahj.2004.12.005_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000013784.18175.51","article-title":"Familial aggregation of low-renin hypertension","volume":"39","author":"Fisher","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.12.005_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.18.1.67","article-title":"Sodium and volume sensitivity of blood pressure: age and pressure change over time","volume":"18","author":"Weinberger","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.12.005_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jama.1992.03480090069029","article-title":"Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy","volume":"267","author":"Blaufox","year":"1992","journal-title":"JAMA"},{"issue":"Suppl 25","key":"10.1016\/j.ahj.2004.12.005_bib7","first-page":"S162","article-title":"Recognizing and treating two types of long-term vasoconstriction in hypertension","volume":"34","author":"Laragh","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2004.12.005_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spironolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2004.12.005_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2004.12.005_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.12.005_bib11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black patients and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl 1","key":"10.1016\/j.ahj.2004.12.005_bib12","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/S0895-7061(02)02333-6","article-title":"Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone\/enalapril combination therapy in diabetic hypertensives with microalbuminuria","volume":"15","author":"Epstein","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2004.12.005_bib13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"The effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-LVH study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.12.005_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone: a selective aldosterone receptor antagonist (SARA)","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.ahj.2004.12.005_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(03)00461-2","article-title":"Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension","volume":"92","author":"White","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2004.12.005_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.12.005_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.jhh.1000395","article-title":"Population characteristics and the modulation of the renin-angiotensin system in the treatment of hypertension","volume":"11","author":"Weir","year":"1997","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ahj.2004.12.005_bib18","first-page":"680","article-title":"Comparative evaluation of losartan and hydrochlorothiazide in elderly patients with mild to moderate hypertension","volume":"22","author":"Gums","year":"1988","journal-title":"Drug Intell Clin Pharm"},{"issue":"Suppl 3","key":"10.1016\/j.ahj.2004.12.005_bib19","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00005344-198900133-00003","article-title":"Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension","volume":"13","author":"Singer","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2004.12.005_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00045415-200203000-00008","article-title":"Aldosterone as a mediator in cardiovascular injury","volume":"10","author":"Stier","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ahj.2004.12.005_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2004.12.005_bib22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure. Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.12.005_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiac tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304009044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304009044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:16:39Z","timestamp":1757567799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304009044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0002870304009044"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.12.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of eplerenone versus losartan in patients with low-renin hypertension","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}